Steven Cohen Pmv Pharmaceuticals, Inc. Transaction History
Point72 Asset Management, L.P.
- $39.3 Billion
- Q1 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 205,855 shares of PMVP stock, worth $374,656. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205,855
Previous 750,153
72.56%
Holding current value
$374,656
Previous $2.33 Million
84.99%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding PMVP
# of Institutions
106Shares Held
45.5MCall Options Held
2KPut Options Held
600-
Orbimed Advisors LLC San Diego, CA6.48MShares$11.8 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.2MShares$5.82 Million0.07% of portfolio
-
Black Rock Inc. New York, NY3.11MShares$5.66 Million0.0% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$4.78 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$4.46 Million0.0% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $83M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...